Sector valuations Protalix BioTherapeutics, Inc.

Stocks

Market Closed - NYSE Other stock markets 00:00:00 27/06/2026 +04			5-day change	1st Jan Change
2.300 ^USD	+3.60%		+3.60%	+27.78%

05-13	Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026
05-13	Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	Price to Book (N)	PEG (N)	EV / Sales (N)	EV / EBITDA (N)	EV / EBIT (N)	Dividend Yield (N)	Capi.($)
PROTALIX BIOTHERAPEUTICS, INC.	11.79x	-	-0.03x	-	-	-	-	185M
ELI LILLY AND COMPANY	35.2x	21.24x	0.71x	12.84x	26.1x	26.96x	0.57%	1,077B
JOHNSON & JOHNSON	27.22x	6.85x	-1.79x	6.26x	17.02x	18.8x	2.1%	613B
ABBVIE INC.	32.17x	-922.25x	0.14x	7.47x	15.29x	15.69x	2.73%	448B
ROCHE HOLDING AG	17.9x	6.65x	1.05x	4.45x	10.94x	12.35x	2.98%	332B
ASTRAZENECA PLC	23.72x	5.52x	1.08x	4.94x	14x	14.72x	1.76%	293B
NOVARTIS AG	21.69x	6.52x	-244.35x	5.59x	13.51x	14.79x	2.83%	286B
NOVO NORDISK A/S	14.19x	6.09x	-5.3x	5.21x	10.72x	12.52x	3.54%	215B
AMGEN INC.	23.3x	17.37x	2.88x	6.21x	10.84x	14.21x	2.81%	193B
GILEAD SCIENCES, INC.	-45.82x	8.69x	0.32x	5.53x	30.47x	61.52x	2.54%	159B
PFIZER INC.	11.36x	1.58x	0.2x	3.03x	7.37x	8.57x	7.21%	138B
VERTEX PHARMACEUTICALS INCORPORATED	28.09x	5.64x	1.98x	8.58x	19.36x	20.15x	-.--%	125B
BRISTOL-MYERS SQUIBB COMPANY	11.27x	4.99x	0.24x	3.09x	8.25x	8.96x	4.37%	117B
GSK PLC	12.56x	4.59x	1.06x	2.76x	8.11x	9.16x	3.53%	104B
SANOFI	11.17x	1.2x	2.22x	2.14x	6.9x	7.84x	5.67%	103B
CHUGAI PHARMACEUTICAL CO., LTD.	24.05x	5.45x	1.4x	8.16x	15.42x	16.13x	1.84%	75.68B
BAYER AG	19.99x	1.63x	-0.12x	1.71x	8.11x	13.62x	0.49%	52.66B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	41.41x	1.09x	60.5x	2.58x	9.49x	26.28x	4.02%	49.71B
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	34.6x	4.68x	1.8x	7.67x	25.59x	28.18x	0.56%	47.27B
Average	18.73x	-45.14x	-9.26x	5.46x	14.30x	18.36x	2.75%	233.13B
Weighted average by Cap.	23.44x	-83.79x	-14.94x	7.29x	17.04x	19.54x	2.26%